UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity

Cell reports (Cambridge), 2019-12, Vol.29 (13), p.4620-4631.e4

2019

Link zum Volltext

Verfügbarkeit prüfen

Acrolein-mediated neuronal cell death and alpha-synuclein aggregation: Implications for Parkinson's disease

Molecular and cellular neuroscience, 2018-04, Vol.88, p.70-82

2018

Link zum Volltext

Verfügbarkeit prüfen

Protective Effects of Polyphenol-Rich Extracts against Neurotoxicity Elicited by Paraquat or Rotenone in Cellular Models of Parkinson's Disease

Antioxidants, 2023-07, Vol.12 (7), p.1463

2023

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson's disease

Brain research, 2014-03, Vol.1555, p.60-77

2014

Link zum Volltext

Verfügbarkeit prüfen

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons

Science (American Association for the Advancement of Science), 2013-11, Vol.342 (6161), p.979-983

2013

Link zum Volltext

Verfügbarkeit prüfen

A mutation map for human glycoside hydrolase genes

Glycobiology (Oxford), 2020-08, Vol.30 (8), p.500-515

2020

Link zum Volltext

Verfügbarkeit prüfen

Mutations in GET4 disrupt the transmembrane domain recognition complex pathway

Journal of inherited metabolic disease, 2020-09, Vol.43 (5), p.1037-1045

2020

Link zum Volltext

Verfügbarkeit prüfen

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitro

Toxicological sciences, 2014-07, Vol.140 (1), p.179-189

2014

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease

Brain research, 2014-03, Vol.1555, p.60-77

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutations in GET4 disrupt the transmembrane domain recognition complex pathway

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Link zum Volltext

Verfügbarkeit prüfen

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Is Selectively Toxic to Primary Dopaminergic Neurons In Vitro

Toxicological sciences, 2014-10, Vol.141 (2), p.560-560

2014

Link zum Volltext

Verfügbarkeit prüfen

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates [alpha]-Synuclein Toxicity in Neurons

Science (American Association for the Advancement of Science), 2013-11, Vol.342 (6161), p.979

2013

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective effects of polyphenols in cellular models of Parkinson's disease

Tambe, Mitali A

2015

Link zum Volltext
ProQuest

Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience

Human gene therapy, 2023-03, Vol.34 (5-6), p.217

2023

Link zum Volltext

Verfügbarkeit prüfen

In depth characterization of midbrain organoids derived from wild type iPSC lines

PloS one, 2023-10, Vol.18 (10), p.e0292926-e0292926

2023

Link zum Volltext

Verfügbarkeit prüfen

Beyond ERAD: N‐glycanase will bring you to tears

The FASEB journal, 2018-04, Vol.32 (S1), p.673.4-673.4

2018

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

Journal of clinical oncology, 2023-01, Vol.41 (2), p.222-232

2023

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson's disease models

Food & function, 2021-11, Vol.12 (23), p.11987-127

2021

Link zum Volltext

Verfügbarkeit prüfen

Generation and characterization of NGLY1 patient-derived midbrain organoids

Frontiers in cell and developmental biology, 2023-02, Vol.11, p.1039182-1039182

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 randomised study evaluating the addition of low-dose nivolumab to palliative chemotherapy in head and neck cancer

Journal of clinical oncology, 2022-06, Vol.40 (17_suppl), p.LBA6016-LBA6016

2022

Link zum Volltext

Verfügbarkeit prüfen

A Dominant Heterozygous Mutation in COG4 Causes Saul-Wilson Syndrome, a Primordial Dwarfism, and Disrupts Zebrafish Development via Wnt Signaling

Frontiers in cell and developmental biology, 2021-09, Vol.9, p.720688-720688

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of conserved transmembrane domain residues in the activation of the dopamine D2 receptor

The FASEB journal, 2009-04, Vol.23 (S1)

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)
Dissertationen
(1)

Sprache

Englisch
(27)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(3)
The Faseb Journal
(3)
Brain Research
(2)
Frontiers In Cell And Developmental Biology
(2)
Journal Of Clinical Oncology
(2)
Science
(2)
Toxicological Sciences
(2)
Antioxidants
(1)
Cell Reports
(1)
Food & Function
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity

Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease

Acrolein-mediated neuronal cell death and alpha-synuclein aggregation: Implications for Parkinson's disease

Protective Effects of Polyphenol-Rich Extracts against Neurotoxicity Elicited by Paraquat or Rotenone in Cellular Models of Parkinson's Disease

Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson's disease

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons

Targeting the Intrinsically Disordered Structural Ensemble of [alpha]-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson's Disease

A mutation map for human glycoside hydrolase genes

Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions

Mutations in GET4 disrupt the transmembrane domain recognition complex pathway

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitro

Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease

Mutations in GET4 disrupt the transmembrane domain recognition complex pathway

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Is Selectively Toxic to Primary Dopaminergic Neurons In Vitro

Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates [alpha]-Synuclein Toxicity in Neurons

Neuroprotective effects of polyphenols in cellular models of Parkinson's disease

Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience

In depth characterization of midbrain organoids derived from wild type iPSC lines

Beyond ERAD: N‐glycanase will bring you to tears

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson's disease models

Generation and characterization of NGLY1 patient-derived midbrain organoids

Phase 3 randomised study evaluating the addition of low-dose nivolumab to palliative chemotherapy in head and neck cancer

A Dominant Heterozygous Mutation in COG4 Causes Saul-Wilson Syndrome, a Primordial Dwarfism, and Disrupts Zebrafish Development via Wnt Signaling

The role of conserved transmembrane domain residues in the activation of the dopamine D2 receptor

Suchergebnisse filtern